Requires health insurers, SHBP, and SEHBP to provide coverage for certain drug regimens for treatment of AIDS or HIV under certain circumstances.
This bill requires New Jersey health insurers, health plans, and state health benefit programs (including SHBP and SEHBP) to cover specific antiretroviral drug regimens for HIV/AIDS treatment. It mandates coverage for single-tablet regimens when equally effective as multi-tablet regimens, and for multi-tablet regimens when clinically equivalent or more effective with better patient adherence (after peer review by infectious disease specialists). Insurers must complete prior authorization requests within 14 days or automatically approve them. The law applies to all relevant health plans, including individual and group policies, and requires coverage at the same level as for other medical conditions.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2024
Last action Jan 9, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 9, 2024
Introduced
Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Gary Schaer
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 2937
Scope: NJ
Hi! I can help you understand A 2937. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline